Vontobel Holding’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Vontobel Holding's VRTX Position: Q2 2026 in Review
Vontobel Holding reduced its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q2 2026, selling an estimated $822K and leaving 81,525 shares worth $40.5M. The position accounts for 0.13% of the portfolio, ranked #157.
Vontobel Holding first reported a position in VRTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $76.1M in Q4 2024. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Vontobel Holding held 81,525 shares of Vertex Pharmaceuticals worth $40.5M as of Q2 2026.
- Vontobel Holding sold 1,855 Vertex Pharmaceuticals shares in Q2 2026, an estimated $822K.
- Vertex Pharmaceuticals made up 0.13% of Vontobel Holding's portfolio in Q2 2026, its #157 holding.
- Vontobel Holding first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
- Vontobel Holding's Vertex Pharmaceuticals position peaked at $76.1M in Q4 2024.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.